Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-25-309666

CEO & President sold 2,662 shares at $20.72 ($55,157)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cox John CEO & President 2025-12-05 Sale 10b5-1 −2,662 $20.72 $55,157 196,877 D: show line 1 in the form
Open-market sales · 2,662 sh · avg $20.72 · $55,157
Loading xslF345X05/ownership.xml…